Obstacles to adherence to azacitidine administration schedule in outpatient myelodysplastic syndrome and related disorders

Support Care Cancer. 2015 Feb;23(2):303-5. doi: 10.1007/s00520-014-2502-y. Epub 2014 Nov 5.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antimetabolites, Antineoplastic / therapeutic use*
  • Azacitidine / therapeutic use*
  • Drug Administration Schedule
  • Female
  • Humans
  • Male
  • Medication Adherence*
  • Middle Aged
  • Myelodysplastic Syndromes / drug therapy*
  • Outpatients

Substances

  • Antimetabolites, Antineoplastic
  • Azacitidine